ARCHIVES

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

This article is from The Cancer Letter archive.

Vol. 35 No. 17 | May 1, 2009

Download PDF Visit The Full Archive

Related Articles

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005

In Brief: Registration Deadlines Coming Up For 13th Cancer Congress; Breast Cancer Meeting Postponed To ‘83

May 28, 1982

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress

October 31, 2003